These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32121123)

  • 21. A model of mucopolysaccharidosis IIIB (Sanfilippo syndrome type IIIB): N-acetyl-alpha-D-glucosaminidase deficiency in Schipperke dogs.
    Ellinwood NM; Wang P; Skeen T; Sharp NJ; Cesta M; Decker S; Edwards NJ; Bublot I; Thompson JN; Bush W; Hardam E; Haskins ME; Giger U
    J Inherit Metab Dis; 2003; 26(5):489-504. PubMed ID: 14518829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene.
    Hartung SD; Reddy RG; Whitley CB; McIvor RS
    Hum Gene Ther; 1999 Sep; 10(13):2163-72. PubMed ID: 10498248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan.
    Chuang CK; Lin HY; Wang TJ; Huang YH; Chan MJ; Liao HC; Lo YT; Wang LY; Tu RY; Fang YY; Chen TL; Ho HC; Chiang CC; Lin SP
    Orphanet J Rare Dis; 2018 May; 13(1):84. PubMed ID: 29801497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice.
    Liu Y; Xu L; Hennig AK; Kovacs A; Fu A; Chung S; Lee D; Wang B; Herati RS; Mosinger Ogilvie J; Cai SR; Parker Ponder K
    Mol Ther; 2005 Jan; 11(1):35-47. PubMed ID: 15585404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.
    Provenzale JM; Nestrasil I; Chen S; Kan SH; Le SQ; Jens JK; Snella EM; Vondrak KN; Yee JK; Vite CH; Elashoff D; Duan L; Wang RY; Ellinwood NM; Guzman MA; Shapiro EG; Dickson PI
    Exp Neurol; 2015 Nov; 273():1-10. PubMed ID: 26222335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10.
    Belur LR; Podetz-Pedersen KM; Tran TA; Mesick JA; Singh NM; Riedl M; Vulchanova L; Kozarsky KF; McIvor RS
    Mol Genet Metab Rep; 2020 Sep; 24():100604. PubMed ID: 32461912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow transplantation for feline mucopolysaccharidosis I.
    Ellinwood NM; Colle MA; Weil MA; Casal ML; Vite CH; Wiemelt S; Hasson CW; O'Malley TM; He X; Prociuk U; Verot L; Melniczek JR; Lannon A; Aguirre GD; Knox VW; Evans SM; Vanier MT; Schuchman EH; Walkley SU; Haskins ME
    Mol Genet Metab; 2007 Jul; 91(3):239-50. PubMed ID: 17482862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
    Barbosa Mendes A; do Nascimento CC; D'Almeida V
    PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive domains in the dog: independence of working memory from object learning, selective attention, and motor learning.
    Zanghi BM; Araujo J; Milgram NW
    Anim Cogn; 2015 May; 18(3):789-800. PubMed ID: 25677729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal opacity in canine MPS I. Changes after bone marrow transplantation.
    Constantopoulos G; Scott JA; Shull RM
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1802-7. PubMed ID: 2503461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometry.
    Oestreich AK; Garcia MR; Yao X; Pfeiffer FM; Nobakhti S; Shefelbine SJ; Wang Y; Brodeur AC; Phillips CL
    Mol Genet Metab Rep; 2015 Dec; 5():3-11. PubMed ID: 28649535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I.
    Mendez DC; Stover AE; Rangel AD; Brick DJ; Nethercott HE; Torres MA; Khalid O; Wong AM; Cooper JD; Jester JV; Monuki ES; McGuire C; Le SQ; Kan SH; Dickson PI; Schwartz PH
    Mol Ther Methods Clin Dev; 2015; 2():14068. PubMed ID: 26052536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
    Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
    Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice.
    Derrick-Roberts ALK; Jackson MR; Pyragius CE; Byers S
    Diseases; 2017 Feb; 5(1):. PubMed ID: 28933358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots.
    Campos D; Monaga M; González EC; Herrera D
    Clin Chim Acta; 2014 Mar; 430():24-7. PubMed ID: 24389097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice.
    Baldo G; Mayer FQ; Martinelli BZ; de Carvalho TG; Meyer FS; de Oliveira PG; Meurer L; Tavares A; Matte U; Giugliani R
    Mol Genet Metab; 2013 May; 109(1):33-40. PubMed ID: 23562162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
    Unger EG; Durrant J; Anson DS; Hopwood JJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward Engineering the Mannose 6-Phosphate Elaboration Pathway in Plants for Enzyme Replacement Therapy of Lysosomal Storage Disorders.
    Zeng Y; He X; Danyukova T; Pohl S; Kermode AR
    J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31842258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene.
    Clarke LA; Russell CS; Pownall S; Warrington CL; Borowski A; Dimmick JE; Toone J; Jirik FR
    Hum Mol Genet; 1997 Apr; 6(4):503-11. PubMed ID: 9097952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.